Newron Pharmaceuticals S.p.A. (0QOI.L) LSE
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 523.09M |
| Enterprise Value | 549.05M |
| P/E Ratio | -20.06 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 14.69 |
| Price/Book Ratio | -24.25 |
| Enterprise/Revenue | 16.05 |
| Enterprise/EBITDA | -67.73 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.69 |
| Operating Margin | -0.25 |
AD
Management Effectiveness
| Return On Assets | -0.33 |
| Return On Equity | 2.78 |
Income Statement
| Revenue | 19.25M |
| Revenue/Share | 0.96 |
| Gross Profit | 0 |
| EBITDA | -4.55M |
| Net Income | -13.33M |
| Diluted EPS | -0.67 |
Balance Sheet
| Total Cash | 28.85M |
| Total Cash/Share | 1.45 |
| Total Debt | 38.13M |
| Total Debt/Equity | -3.43 |
| Current Ratio | 0.76 |
| Book Value Per Share | -0.56 |
Price History
| 52-Week Change | 81.79 |
| 52-Week High | 12.38 |
| 52-Week Low | 4.12 |
| Moving Average 50 Days | 7.53 |
| Moving Average 200 Days | 5.82 |
Statistics
| Average Volume | 4,223 |
| Shares Outstanding | 20.01M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
